AvaSure

AvaSure addresses un-witnessed patient falls, elopement, and self-harm events — three of the most expensive and common liability categories in acute-care settings. Its platform replaces periodic in-room checks with continuous AI-driven video monitoring, where computer vision models detect risky patient movements and trigger immediate verbal interventions. Hospitals report substantial reductions in fall rates and sitter costs following deployment, supported by clinical studies citing 50–80% declines in fall-related incidents.

Waud Capital Partners, a Chicago-based private equity firm, made a strategic growth investment in AvaSure in November 2023, acquiring a controlling interest. Founder Brad Playford transitioned to Board Chair at that time, and Adam McMullin, a healthcare technology executive with prior CEO experience at HealthSparq, was appointed CEO. The governance structure reflects a PE-backed growth posture with founder continuity at the board level.

AvaSure's platform applies deep learning and computer vision to interpret patient behavior — not just detect motion. The system classifies specific risk poses, such as a patient attempting to rise unassisted, and triggers graded interventions ranging from automated verbal prompts to direct staff alerts via existing nurse-call infrastructure. This inferencing occurs on edge hardware within hospital walls, avoiding cloud-dependent latency or external data exposure, which is critical for hospital compliance.

AvaSure operates on a hardware-as-a-service model that bundles fixed and mobile camera units, software licensing, and 24/7 algorithmic monitoring into a single per-bed, per-month fee. This includes access to trained remote monitoring technicians who escalate to on-site staff when automated interventions are insufficient. The model aligns with hospital capital-avoidance preferences, shifting video surveillance from a large upfront capex line item to an operating expense.

AvaSure has publicly confirmed deployments with HCA Healthcare, Ascension, and Providence, among other large health systems, representing over 1,000 hospital facilities as of 2024. These relationships span acute-care medical-surgical units, behavioral health settings, and emergency departments. The firm's direct-enterprise sales motion targets chief nursing officers and patient safety leaders rather than traditional IT procurement channels.

No. AvaSure is a single-line operating company that develops and deploys a clinical AI platform — it does not invest in external funds, make venture commitments, or operate as a family office or fund manager. Its capital structure is institutional private equity via Waud Capital Partners, and its deployment activity consists of internal product development and enterprise sales, not portfolio investing.

Three structural moats protect AvaSure's position: a large installed base of proprietary camera hardware inside hospital IT environments, creating high physical switching costs; a multi-year dataset of annotated clinical video that trains increasingly accurate computer vision models, representing a data network effect; and deep integration with nurse-call and electronic health record workflows, which means removal disrupts clinical operations. No broad-based EHR vendor or telehealth platform has replicated this integrated hardware-software-AI stack at comparable scale in the acute-care video monitoring segment.